Novo Nordisk A/S (NVO)

38.68
NYSE : Health Care
Prev Close 38.78
Day Low/High 38.32 / 39.02
52 Wk Low/High 30.89 / 57.44
Avg Volume 2.53M
Exchange NYSE
Shares Outstanding 2.55B
Market Cap 98.89B
EPS 2.00
Div & Yield 1.33 (3.40%)

Latest News

What to Expect From European Pharmaceuticals' First Quarter Results

What to Expect From European Pharmaceuticals' First Quarter Results

New drug launches and late stage trials will be under the microscope as eight European pharmaceuticals companies report Q1 earnings starting next week.

Novo Nordisk Invites The Community To Unmask Everyday Heroes In Recognition Of World Hemophilia Day

Novo Nordisk Invites The Community To Unmask Everyday Heroes In Recognition Of World Hemophilia Day

#HemoHero stories to illustrate diverse experiences and inspiring acts of people affected by hemophilia

IIROC Trading Resumption - NVO

IIROC Trading Resumption - NVO

IIROC Trading Halt - NVO

IIROC Trading Halt - NVO

Delta, Barracuda Networks, STMicroelectronics: 'Mad Money' Lightning Round

Delta, Barracuda Networks, STMicroelectronics: 'Mad Money' Lightning Round

Jim Cramer is bullish on Delta, Barracuda Networks, STMicroelectronics, UnitedHealth Group.

Deregulation and Energy Policy Can Fuel Markets: Cramer's 'Mad Money' Recap (Friday 3/17/17)

Deregulation and Energy Policy Can Fuel Markets: Cramer's 'Mad Money' Recap (Friday 3/17/17)

This week the markets fell back on earnings -- like Adobe -- and remained afloat, says Jim Cramer.

SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Novo Nordisk A/S And Encourages Investors With Losses To Contact The Firm

SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Novo Nordisk A/S And Encourages Investors With Losses To Contact The Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Novo Nordisk A/S (" Novo" or the "Company") (NYSE: NVO).

Egalet Makes Friday's Biotech Mailbag

Egalet Makes Friday's Biotech Mailbag

Why the name is sagging, and what it will take to spur the sector higher.

Global Blood Therapeutics Shares Jump on Report It Was Approached by Novo Nordisk

Global Blood Therapeutics Shares Jump on Report It Was Approached by Novo Nordisk

While it's not a surprise that Global Blood is a takeout target, the timing of Novo Nordisk's interest in the company comes as a surprise, according to a stock analyst.

Is This a Market Top or Just Consolidation?

Is This a Market Top or Just Consolidation?

Afternoon surge is surfacing again.

Global Blood Therapeutics Stock Surging on Nordisk Bid Speculation

Global Blood Therapeutics Stock Surging on Nordisk Bid Speculation

Global Blood Therapeutics is said to have been approached about a merger by Novo Nordisk.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Novo Nordisk A/S Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of March 13, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Novo Nordisk A/S Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of March 13, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired American Depositary Receipts of Novo Nordisk A/S (NYSE: NVO) between February...

NVO INVESTORS ALERT: Lieff Cabraser Reminds Investors Of Deadline In Class Action Against Novo Nordisk A/S

NVO INVESTORS ALERT: Lieff Cabraser Reminds Investors Of Deadline In Class Action Against Novo Nordisk A/S

The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in securities class litigation brought on behalf of investors who purchased...

NVO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Novo Nordisk A/S And A Lead Plaintiff Deadline Of March 13, 2017

NVO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Novo Nordisk A/S And A Lead Plaintiff Deadline Of March 13, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Novo Nordisk A/S (NYSE: NVO) securities between April...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Novo Nordisk A/S Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of March 13, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Novo Nordisk A/S Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of March 13, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired American Depositary Receipts of Novo Nordisk A/S (NYSE:NVO) between February 5,...

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Novo Nordisk A/S To Contact The Firm

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Novo Nordisk A/S To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

NVO INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Novo Nordisk A/S

NVO INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Novo Nordisk A/S

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Novo Nordisk A/S ("Novo...

NVO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Novo Nordisk A/S And A Lead Plaintiff Deadline Of March 13, 2017

NVO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Novo Nordisk A/S And A Lead Plaintiff Deadline Of March 13, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Novo Nordisk A/S (NYSE: NVO) securities between April...